KCM
KYNB

Kennedy Capital Management’s Kyntra Bio KYNB Stock Holding History

Kennedy Capital Management’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-3,601
Closed -$5.47M – 701
2018
Q3 		$5.47M Buy
3,601
+99
+3% +$152K 0.1% 370
2018
Q2 		$5.48M Buy
3,502
+1,148
+49% +$1.5M 0.1% 383
2018
Q1 		$2.72M Sell
2,354
-39
-2% -$51.4K 0.05% 552
2017
Q4 		$2.83M Buy
+2,393
New +$3M 0.05% 572

Other funds holding KYNB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Kennedy Capital Management's KYNB Position: Q4 2018 in Review

Kennedy Capital Management sold out of Kyntra Bio (KYNB) in Q4 2018, closing a stake of 3,601 shares — an estimated $5.47M sold.

Kennedy Capital Management first reported a position in KYNB in Q4 2017 and held it in 4 quarters. The position peaked at $5.48M in Q2 2018. 201 funds tracked by Wall St. Rank hold KYNB as of Q4 2018.

  • Kennedy Capital Management reported no remaining Kyntra Bio position as of Q4 2018 after selling out during the quarter.
  • Kennedy Capital Management sold 3,601 Kyntra Bio shares in Q4 2018, an estimated $5.47M.
  • Kennedy Capital Management first reported a position in Kyntra Bio in Q4 2017 and held it in 4 quarters.
  • Kennedy Capital Management's Kyntra Bio position peaked at $5.48M in Q2 2018.
  • 201 funds tracked by Wall St. Rank held Kyntra Bio as of Q4 2018.

Based on Kennedy Capital Management's 13F filing for Q4 2018, filed 12 Feb 2019.